Skip to main content
. 2023 Jan 12;66(2):1380–1425. doi: 10.1021/acs.jmedchem.2c01597

Figure 1.

Figure 1

Evolution of a potent gyrase inhibitor 1 with antibacterial activity as a starting point for hit-to-lead optimization.